Showing results (291-300 of 302) with videos related to
Sort By:
Pageof 31
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Receptors for pituitary adenylate cyclase-activating peptide in human liverL G Guijarro, N Rodriguez-Henche, E García-López, et al.FEBS Letters|April 7, 1997
Identification of a protein-tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostateA M Valencia, J L Oliva, G Bodega, et al.International Journal of Cancer|March 12, 1992
Basic fibroblast growth factor induces proliferation of a rat pancreatic cancer cell line. Inhibition by somatostatinM Bensaïd, N Tahiri-Jouti, C Cambillau, et al.Cellular Signalling|February 1, 1994
Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic ratsM S Rodriguez-Pena, L G Guijarro, M G Juarranz, et al.The Prostate|November 14, 2000
Effects of Pygeum africanum extract (Tadenan) on vasoactive intestinal peptide receptors, G proteins, and adenylyl cyclase in rat ventral prostateR M Solano, M O García-Fernández, C Clemente, et al.Revista Medica De Chile|December 1, 1989
[Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis]M Ligueros, R Cruz Coke, S Neira, et al.Cellular Signalling|December 1, 2001
Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptorsM G Juarranz, O Bolaños, I Gutiérrez-Cañas, et al.Actas Urologicas Espanolas|July 14, 2004
[Phosphotyrosine phosphatase SHP-1, somatostatin and prostate cancer]P D Zapata, B Colas, P López-Ruiz, et al.Journal of Pharmaceutical Sciences|August 1, 1993
Synthesis and structural, biochemical, and pharmacological study of 3 beta-acyloxy-3 alpha-methoxycarbonyltropane derivativesE Gálvez, M L Izquierdo, C Burgos, et al.Endocrinology|July 1, 1996
Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostateR M Solano, M J Carmena, I Carrero, et al.Pageof 31